Macquarie Group LTD Xencor Inc Transaction History

Macquarie Group LTD

  • $85.1 Billion
  • Q2 2024

A detailed history of Macquarie Group LTD transactions in Xencor Inc stock. As of the latest transaction made, Macquarie Group LTD holds 200,000 shares of XNCR stock, worth $4.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
200,000
Previous 200,000 -0.0%
Holding current value
$4.05 Million
Previous $4.43 Million 14.46%
% of portfolio
0.0%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$18.65 - $26.52 $1.32 Million - $1.88 Million
70,809 Added 54.81%
200,000 $4.43 Million
Q4 2022

Feb 21, 2023
SELL
$24.79 - $30.86 $13,386 - $16,664
-540 Reduced 0.42%
129,191 $3.36 Million
Q3 2022

Nov 14, 2022
SELL
$24.62 - $32.44 $27,599 - $36,365
-1,121 Reduced 0.86%
129,731 $3.4 Million
Q1 2021

May 14, 2021
SELL
$40.81 - $53.88 $21,670 - $28,610
-531 Reduced 0.4%
130,852 $5.64 Million
Q2 2020

Aug 11, 2020
BUY
$27.76 - $33.42 $60,849 - $73,256
2,192 Added 1.7%
131,383 $4.26 Million
Q2 2019

Nov 06, 2019
BUY
$29.6 - $40.93 $3.82 Million - $5.29 Million
129,191 New
129,191 $5.29 Million
Q2 2019

Aug 14, 2019
SELL
$29.6 - $40.93 $3.82 Million - $5.29 Million
-129,191 Closed
0 $0
Q1 2019

May 15, 2019
SELL
$27.85 - $38.09 $2,785 - $3,809
-100 Reduced 0.08%
129,191 $4.01 Million
Q3 2018

Nov 15, 2018
BUY
$35.69 - $47.65 $3,569 - $4,765
100 Added 0.08%
129,291 $5.04 Million
Q1 2018

May 11, 2018
BUY
$21.18 - $33.78 $710,546 - $1.13 Million
33,548 Added 35.08%
129,191 $3.87 Million
Q4 2017

Feb 15, 2018
BUY
$19.29 - $24.83 $784,003 - $1.01 Million
40,643 Added 73.9%
95,643 $2.1 Million
Q3 2017

Nov 08, 2017
BUY
$19.61 - $23.35 $1.08 Million - $1.28 Million
55,000
55,000 $1.26 Million

Others Institutions Holding XNCR

# of Institutions
204
Shares Held
63.1M
Call Options Held
3.9K
Put Options Held
3K
View Full List

About Xencor Inc

XNCR Quotes by TradingView
  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.21B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email